Clinical study of Vitamin D Deficiency in Type 2 Diabetes Mellitus, Hypertension and Chronic Kidney Disease Patients

Kuldeep Deopujari; Abhinav Nair; Sachin Chittawar; Ravish Saraf

Volume : VII, Issue : VIII, August - 2018

Clinical study of Vitamin D Deficiency in Type 2 Diabetes Mellitus, Hypertension and Chronic Kidney Disease Patients

Kuldeep Deopujari, Abhinav Nair, Sachin Chittawar, Ravish Saraf

Abstract :

Vitamin D is an essential nutrient, a fat soluble vitamin and is known for its role in calcium homeostasis, which is vital for optimal skeletal health. Epidemiological studies have suggested a higher prevalence of metabolic syndrome and its components among individuals with vitamin deficiency. Humans get Vitamin D from exposure to sunlight, from their diets, and from dietary supplements. Calcium is actively absorbed from the small intestine in the presence of Vitamin D. Vitamin D refers to Vitamin D2(ergocalciferol) or Vitamin D3(cholecalciferol). The best marker of Vitamin D status is the serum 25–hydroxyvitamin D concentration. The 25–hydroxyvitamin D level is measured in patients with suspected Vitamin D deficiency. This study was undertaken to determine the prevalence of Vitamin D deficiency in general and the comparison of this data with type 2 DM , hypertensive and chronic kidney disease patients, patients were divided into 4 groups and a prospective, observational, open and controlled study was conducted on indoor and outdoor patients with the conclusion being that there was a significantly lower level of Vitamin D in patients with type 2 Diabetes mellitus and an extremely significant result of higher levels of Vitamin D in CKD cases compared to controls.